The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 3×
“…drug treatment, growth factor withdrawal and is followed by transactivation of p53 targets p21/Waf1, Bax, murine double minute 2 (MDM2), etc. (Vogelstein et al., 2000). p21/Waf1 is an Received 19 February 2003; revised 21 March 2003; accepted 21 March 2003 *Correspondence: H Mukhtar; E-mail:…”
BackgroundTumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 1×
“This transcription factor regulates cell cycle progression, checkpoint activation (El-Deiry et al., 1994; Budram-Mahadeo et al., 2002), apoptosis (Miyashita and Reed, 1995; Budram-Mahadeo et al., 2002; Wu and Deng, 2002) and repair of DNA damage (Vogelstein et al., 2000).”
BackgroundRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“The stability of p53 is determined by its transcriptional target MDM2 which acts as an E3 ligase and targets p53 to proteasomal degradation (Kubbutat et al., 1997).”
BackgroundLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 1×
“Phosphorylation of p53 at serine 15 and 20 has been shown to stimulate p53-dependent transcriptional activation (Dumaz and Meek, 1999) and also results in reduced interaction of p53 with its negative regulator MDM2 both in vivo and in vitro (Shieh et al., 1997).”
BackgroundRel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
The INK4a/ARF network in tumour suppression
Sherr, C. J. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096061 · Cited by 996
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940
The machinery of programmed cell death
Zimmermann, K. C., Bonzon, C., & Green, D. R. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00159-0 · Cited by 833
The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x L
Chen, C., Edelstein, L. C., & Gélinas, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2687-2695.2000 · Cited by 760
Cited by
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
Tea Polyphenols for Health Promotion
Khan, N., & Mukhtar, H. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.06.011 · Cited by 1,156
Self-citationCancer Chemoprevention Through Dietary Antioxidants: Progress and Promise
Khan, N., Afaq, F., & Mukhtar, H. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1740 · Cited by 591
Self-citationPerspectives for Cancer Prevention With Natural Compounds
Amin, A. R. M. R., Kucuk, O., Khuri, F. R., & Shin, D. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6235 · Cited by 572
Anti-cancer potential of flavonoids: recent trends and future perspectives
Batra, P., & Sharma, A. K. (2013) · 3 Biotech · doi:10.1007/s13205-013-0117-5 · Cited by 550
Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases
Weinreb, O., Mandel, S., Amit, T., & Youdim, M. B. H. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.05.002 · Cited by 505
Na, H.-K., & Surh, Y.-J. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.10.006 · Cited by 485
Cancer Prevention With Natural Compounds
Gullett, N. P., Ruhul Amin, A. R. M., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y.-J., & Kucuk, O. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 485
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
Phytochemicals and regulation of the adipocyte life cycle
Rayalam, S., Della-Fera, M. A., & Baile, C. A. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.12.007 · Cited by 449
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases
Mandel, S., & Youdim, M. B. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.012 · Cited by 445
Mandel, S., Weinreb, O., Amit, T., & Youdim, M. B. H. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02291.x · Cited by 377
Multitargeted therapy of cancer by green tea polyphenols
Khan, N., & Mukhtar, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.04.014 · Cited by 363
Self-citationChanging demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Singh, N. A., Mandal, A. K. A., & Khan, Z. A. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0179-4 · Cited by 314
Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Brahmkhatri, V. P., Prasanna, C., & Atreya, H. S. (2015) · BioMed Research International · doi:10.1155/2015/538019 · Cited by 279
Chemosensitization and Radiosensitization of Tumors by Plant Polyphenols
Garg, A. K., Buchholz, T. A., & Aggarwal, B. B. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1630 · Cited by 278
Na, H.-K., Kim, E.-H., Jung, J.-H., Lee, H.-H., Hyun, J.-W., & Surh, Y.-J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.003 · Cited by 268
Upreti, M., Jyoti, A., Johnson, S. E., Swindell, E. P., Napier, D., Sethi, P., Chan, R., Feddock, J. M., Weiss, H. L., O’Halloran, T. V., et al. (2106) · Oncotarget · doi:10.18632/oncotarget.9490 · Cited by 21
Metadata
- Authors
- Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K., Agarwal, M. L., & Mukhtar, H.
- Venue
- Oncogene
- Published
- 2003-07-31
- Volume
- 22
- Issue
- 31
- Pages
- 4851-4859
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2036809593
- Cited by
- 325
- References
- 35
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.